By Marius Meland ( November 5, 2003, 12:00 AM EST) -- In a move likely to set off a tidal wave of litigation, the U.S. Food and Drug Administration approved a generic version of Pfizer's hypertension medication Norvasc by Indian generics maker Dr. Reddy's Laboratories Ltd. through a hotly disputed approval pathway, the Wall Street Journal reported Wednesday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.